NLS Pharmaceutics AG (NLSPW)
USD 0.01
(9.8%)
USD 0.01
(9.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 11.4 Thousand | 11.4 Thousand | 10.05 Thousand | - | - | - |
| Gross Profit | -11.4 Thousand | -11.4 Thousand | -10.05 Thousand | - | - | - |
| Operating Expenses | 11.8 Million | 15.47 Million | 11.85 Million | 2.29 Million | 4.19 Million | 3.44 Million |
| Selling, General and Administrative Expenses | 5.89 Million | 6.49 Million | 5.93 Million | 2.19 Million | 2.49 Million | 2.01 Million |
| Research and Development Expenses | 5.9 Million | 8.97 Million | 5.91 Million | 99.58 Thousand | 1.7 Million | 1.43 Million |
| Other Expenses | - | 10.04 Thousand | -17.32 Thousand | -328.36 Thousand | - | -629.23 Thousand |
| Cost and Expenses | 11.8 Million | 15.48 Million | 11.86 Million | 2.29 Million | 4.19 Million | 3.44 Million |
| Operating Income | -11.8 Million | -15.48 Million | -11.86 Million | -2.29 Million | -4.19 Million | -3.44 Million |
| Interest Expense | 145.15 Thousand | 100.86 Thousand | 68.13 Thousand | 233.7 Thousand | 819.71 Thousand | 1.06 Million |
| Income Tax Expense | - | 2.00 | -226.5 Thousand | -2299.37 | -4197.04 | 1.69 Million |
| Earnings before Tax | -12.17 Million | -16.49 Million | -11.94 Million | -2.86 Million | -5.44 Million | -5.14 Million |
| Net Income | -12.17 Million | -16.49 Million | -11.94 Million | -2.86 Million | -5.44 Million | -5.14 Million |
| Earnings Per Share Basic | -0.32 | -0.84 | -0.81 | -0.59 | -0.49 | -0.44 |
| Earnings Per Share Diluted | -0.32 | -0.84 | -0.81 | -0.59 | -0.49 | -0.44 |
| Weighted Average Shares Outstanding | 38.17 Million | 19.68 Million | 14.74 Million | 4.81 Million | 11.14 Million | 11.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.17 Million | 19.68 Million | 14.74 Million | 4.81 Million | 11.14 Million | 11.77 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -11.79 Million | -15.47 Million | -11.85 Million | - | -430.4 Thousand | -613.19 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 5704.00 | 11.4 Thousand | 5704.00 | 5704.00 | 11.4 Thousand | 5704.00 |
| Gross Profit | -5704.00 | -11.4 Thousand | -5704.00 | -5704.00 | -11.4 Thousand | -5704.00 |
| Operating Expenses | 2.04 Million | 11.79 Million | 4257.58 | 7.54 Million | 15.47 Million | 6.78 Million |
| Selling, General and Administrative Expenses | 1.77 Million | - | 2732.92 | 3.16 Million | - | 3.35 Million |
| Research and Development Expenses | 271.35 Thousand | - | 1524.66 | 4.38 Million | - | 3.43 Million |
| Other Expenses | - | - | - | - | 10.04 Thousand | - |
| Cost and Expenses | 2.05 Million | 11.8 Million | 4257.58 | 7.54 Million | 15.48 Million | 6.79 Million |
| Operating Income | -2.05 Million | -11.8 Million | -4257.58 | -7.54 Million | -15.48 Million | -6.79 Million |
| Interest Expense | 86.98 Thousand | 145.15 Thousand | 145.02 Thousand | 129.00 | 100.86 Thousand | 91.68 Thousand |
| Income Tax Expense | 104.64 Thousand | 2.00 | -4.00 | -4.00 | 2.00 | -4.00 |
| Earnings before Tax | -2.03 Million | -12.17 Million | -4559.29 | -7.61 Million | -16.49 Million | -7.85 Million |
| Net Income | -2.03 Million | -12.17 Million | -4559.29 | -7.61 Million | -16.49 Million | -7.85 Million |
| Earnings Per Share Basic | -0.05 | - | -0.14 | -0.20 | - | -0.29 |
| Earnings Per Share Diluted | -0.05 | - | -0.14 | -0.20 | - | -0.29 |
| Weighted Average Shares Outstanding | 41.94 Million | 38.17 Million | 32.42 Million | 38.17 Million | 19.68 Million | 26.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.94 Million | 38.17 Million | 32.42 Million | 38.17 Million | 19.68 Million | 26.68 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.94 Million | - | -4251.88 | -7.54 Million | - | -6.78 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CPH
BDM
FBYDW
H2G
6866
GNTX